Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogs (Q73139109)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063692%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063692%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

T Yatsu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063692%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Y Tomura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063692%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Tahara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063692%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

K Wada

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063692%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J Tsukada

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063692%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

W Uchida

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063692%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Tanaka

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063692%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Takenaka

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063692%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 February 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063692%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063692%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

321

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063692%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063692%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

225-230

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063692%20AND%20SRC:MED&resulttype=core&format=json

Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900940-5

Norepinephrine, vasopressin, glucagon, and A23187 induce efflux of calcium from an exchangeable pool in isolated rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900940-5

Pharmacological characterization of vasopressin aggregation response of human platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900940-5

Vascular vasopressin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900940-5

Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900940-5

Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900940-5

Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900940-5

Effects of vasopressin V1 and V2 receptor antagonists on progressive renal failure in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900940-5

Identification of functional oxytocin receptors in lactating rat mammary gland in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900940-5

Aquaretic effects of the nonpeptide V2 antagonist OPC-31260 in hydropenic humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900940-5

Characterization of human platelet vasopressin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900940-5

Vasopressin inhibits the adenylate cyclase activity of human platelet particulate fraction through V1‐receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900940-5

Nature and properties of human platelet vasopressin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900940-5

OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor Antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900940-5

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900940-5

10.1016/S0014-2999(96)00940-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9063692%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference